Literature DB >> 12029060

Catabolite repression of Escherichia coli biofilm formation.

Debra W Jackson1, Jerry W Simecka, Tony Romeo.   

Abstract

Biofilm formation was repressed by glucose in several species of Enterobacteriaceae. In Escherichia coli, this effect was mediated at least in part by cyclic AMP (cAMP)-cAMP receptor protein. A temporal role for cAMP in biofilm development was indicated by the finding that glucose addition after approximately 24 h failed to repress and generally activated biofilm formation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12029060      PMCID: PMC135108          DOI: 10.1128/JB.184.12.3406-3410.2002

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  30 in total

1.  The outer membrane protein, antigen 43, mediates cell-to-cell interactions within Escherichia coli biofilms.

Authors:  P N Danese; L A Pratt; S L Dove; R Kolter
Journal:  Mol Microbiol       Date:  2000-07       Impact factor: 3.501

Review 2.  Cyclic AMP in prokaryotes.

Authors:  J L Botsford; J G Harman
Journal:  Microbiol Rev       Date:  1992-03

3.  Genetic regulation of glycogen biosynthesis in Escherichia coli: in vitro effects of cyclic AMP and guanosine 5'-diphosphate 3'-diphosphate and analysis of in vivo transcripts.

Authors:  T Romeo; J Preiss
Journal:  J Bacteriol       Date:  1989-05       Impact factor: 3.490

4.  The product of the pleiotropic Escherichia coli gene csrA modulates glycogen biosynthesis via effects on mRNA stability.

Authors:  M Y Liu; H Yang; T Romeo
Journal:  J Bacteriol       Date:  1995-05       Impact factor: 3.490

5.  Regulation of Salmonella enterica serovar typhimurium invasion genes by csrA.

Authors:  C Altier; M Suyemoto; S D Lawhon
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

6.  A collection of strains containing genetically linked alternating antibiotic resistance elements for genetic mapping of Escherichia coli.

Authors:  M Singer; T A Baker; G Schnitzler; S M Deischel; M Goel; W Dove; K J Jaacks; A D Grossman; J W Erickson; C A Gross
Journal:  Microbiol Rev       Date:  1989-03

7.  Identification and molecular characterization of csrA, a pleiotropic gene from Escherichia coli that affects glycogen biosynthesis, gluconeogenesis, cell size, and surface properties.

Authors:  T Romeo; M Gong; M Y Liu; A M Brun-Zinkernagel
Journal:  J Bacteriol       Date:  1993-08       Impact factor: 3.490

8.  Isolation and expression of the Bradyrhizobium japonicum adenylate cyclase gene (cya) in Escherichia coli.

Authors:  M L Guerinot; B K Chelm
Journal:  J Bacteriol       Date:  1984-09       Impact factor: 3.490

9.  A lowered concentration of cAMP receptor protein caused by glucose is an important determinant for catabolite repression in Escherichia coli.

Authors:  H Ishizuka; A Hanamura; T Kunimura; H Aiba
Journal:  Mol Microbiol       Date:  1993-10       Impact factor: 3.501

10.  Hemagglutination of human group A erythrocytes by enterotoxigenic Escherichia coli isolated from adults with diarrhea: correlation with colonization factor.

Authors:  D G Evans; D J Evans; W Tjoa
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

View more
  62 in total

1.  Structural studies of the Nudix GDP-mannose hydrolase from E. coli reveals a new motif for mannose recognition.

Authors:  Agedi N Boto; Wenlian Xu; Jean Jakoncic; Archana Pannuri; Tony Romeo; Maurice J Bessman; Sandra B Gabelli; L Mario Amzel
Journal:  Proteins       Date:  2011-06-02

Review 2.  Pseudomonad reverse carbon catabolite repression, interspecies metabolite exchange, and consortial division of labor.

Authors:  Heejoon Park; S Lee McGill; Adrienne D Arnold; Ross P Carlson
Journal:  Cell Mol Life Sci       Date:  2019-11-25       Impact factor: 9.261

3.  A small RNA that regulates motility and biofilm formation in response to changes in nutrient availability in Escherichia coli.

Authors:  Maureen K Thomason; Fanette Fontaine; Nicholas De Lay; Gisela Storz
Journal:  Mol Microbiol       Date:  2012-01-30       Impact factor: 3.501

4.  c-di-GMP (3'-5'-cyclic diguanylic acid) inhibits Staphylococcus aureus cell-cell interactions and biofilm formation.

Authors:  David K R Karaolis; Mohammed H Rashid; Rajanna Chythanya; Wensheng Luo; Mamoru Hyodo; Yoshihiro Hayakawa
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

5.  Genetic and functional characterization of the Escherichia coli BarA-UvrY two-component system: point mutations in the HAMP linker of the BarA sensor give a dominant-negative phenotype.

Authors:  Henrik Tomenius; Anna-Karin Pernestig; Claudia F Méndez-Catalá; Dimitris Georgellis; Staffan Normark; Ojar Melefors
Journal:  J Bacteriol       Date:  2005-11       Impact factor: 3.490

6.  YliH (BssR) and YceP (BssS) regulate Escherichia coli K-12 biofilm formation by influencing cell signaling.

Authors:  Joanna Domka; Jintae Lee; Thomas K Wood
Journal:  Appl Environ Microbiol       Date:  2006-04       Impact factor: 4.792

7.  Spatial periodicity of Escherichia coli K-12 biofilm microstructure initiates during a reversible, polar attachment phase of development and requires the polysaccharide adhesin PGA.

Authors:  Konstantin Agladze; Xin Wang; Tony Romeo
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

8.  The Catabolite Repressor Protein-Cyclic AMP Complex Regulates csgD and Biofilm Formation in Uropathogenic Escherichia coli.

Authors:  David A Hufnagel; Margery L Evans; Sarah E Greene; Jerome S Pinkner; Scott J Hultgren; Matthew R Chapman
Journal:  J Bacteriol       Date:  2016-11-18       Impact factor: 3.490

9.  A novel role for enzyme I of the Vibrio cholerae phosphoenolpyruvate phosphotransferase system in regulation of growth in a biofilm.

Authors:  Laetitia Houot; Paula I Watnick
Journal:  J Bacteriol       Date:  2007-11-02       Impact factor: 3.490

Review 10.  Escherichia coli biofilms.

Authors:  C Beloin; A Roux; J M Ghigo
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.